​

TransMedics Group (TMDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

TransMedics Group Revenue Highlights

Latest Revenue (Y)

$441.54M

Latest Revenue (Q)

$157.37M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

TransMedics Group Revenue by Period

TransMedics Group Revenue by Year

DateRevenueChange
2024-12-31$441.54M82.74%
2023-12-31$241.62M158.53%
2022-12-31$93.46M208.83%
2021-12-31$30.26M18.03%
2020-12-31$25.64M8.62%
2019-12-28$23.60M81.33%
2018-12-31$13.02M69.38%
2017-12-31$7.68M23.77%
2016-12-31$6.21M-

TransMedics Group generated $441.54M in revenue during NA 2024, up 82.74% compared to the previous quarter, and up 1870.62% compared to the same period a year ago.

TransMedics Group Revenue by Quarter

DateRevenueChange
2025-06-30$157.37M9.64%
2025-03-31$143.54M18.02%
2024-12-31$121.62M11.83%
2024-09-30$108.76M-4.85%
2024-06-30$114.31M18.02%
2024-03-31$96.85M19.31%
2023-12-31$81.17M22.19%
2023-09-30$66.43M26.62%
2023-06-30$52.47M26.26%
2023-03-31$41.55M32.44%
2022-12-31$31.38M22.16%
2022-09-30$25.68M25.15%
2022-06-30$20.52M29.23%
2022-03-31$15.88M64.25%
2021-12-31$9.67M80.04%
2021-09-30$5.37M-34.28%
2021-06-30$8.17M15.85%
2021-03-31$7.05M-7.53%
2020-12-31$7.63M7.56%
2020-09-30$7.09M109.11%
2020-06-30$3.39M-54.97%
2020-03-31$7.53M24.32%
2019-12-28$6.06M-15.93%
2019-09-28$7.21M27.16%
2019-06-29$5.67M21.17%
2019-03-30$4.68M31.94%
2018-12-31$3.54M-12.26%
2018-09-30$4.04M38.56%
2018-06-30$2.92M15.72%
2018-03-31$2.52M19.61%
2017-12-30$2.11M12.80%
2017-09-30$1.87M-16.35%
2017-07-01$2.23M-

TransMedics Group generated $157.37M in revenue during Q2 2025, up 9.64% compared to the previous quarter, and up 162.49% compared to the same period a year ago.

TransMedics Group Revenue Breakdown

TransMedics Group Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Product$273.87M$176.05M$79.23M--
Service Revenue$167.67M$65.55M$14.22M--
Ocs Liver Product---$1.91M$5.25M
Ocs Heart Product---$17.68M$14.20M
Ocs Lung Product---$10.66M$6.19M

TransMedics Group's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (62.03%), and Service Revenue (37.97%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Service$61.27M$55.30M$42.90M$42.57M$35.52M$14.68M$10.00M$7.56M------------
Product$96.10M$88.23M$74.95M$65.86M$71.73M$61.33M$88.51M$11.09M$42.46M$33.99M----------
Ocs Liver Product----------$12.54M$9.62M$7.87M$1.47M--$442.00K$2.12M$1.00M$736.00K
Ocs Heart Product----------$11.54M$8.06M$5.71M$6.05M$2.85M$4.60M$4.18M$2.42M$5.43M$2.22M
Ocs Lung Product----------$1.60M$2.84M$2.30M$2.14M$2.52M$3.57M$2.43M$3.09M$659.00K$435.00K

TransMedics Group's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (61.07%), and Service (38.93%).

TransMedics Group Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19
UNITED STATES$7.97M$21.86M$19.24M$16.25M
Other Countries$880.00K$3.97M--
Non Us And Uk-$8.40M$6.40M-
GERMANY---$1.15M

TransMedics Group's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (90.05%), and Other Countries (9.95%).

Quarterly Revenue by Country

CountryJun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
UNITED STATES$2.82M$37.50M$29.05M$23.29M$18.14M$13.56M$7.23M$5.76M$5.76M$5.67M$5.92M$2.44M$5.21M$4.66M$4.34M$4.30M$2.95M-
Other Countries$403.00K$4.05M$2.32M$2.40M$1.20M$1.65M$139.00K-----------
Non Us And Uk----$2.38M$2.32M$4.36M$1.90M$1.31M$824.00K$4.10M$491.00K$596.00K-----
U S-------$3.11M----------
Non US And UK-------------$1.21M----
GERMANY--------------$276.00K$194.00K$358.00K-
AUSTRALIA---------------$251.00K$175.00K-
ITALY----------------$287.00K-
Non-US-----------------$1.72M

TransMedics Group's latest quarterly revenue breakdown by geography, as of Jun 23: UNITED STATES (87.48%), and Other Countries (12.52%).

TransMedics Group Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ITGRInteger$1.72B$467.69M
LNTHLantheus$1.53B$378.05M
LIVNLivaNova$1.25B$316.86M
ACADACADIA Pharmaceuticals$957.80M$264.57M
INSPInspire Medical Systems$802.80M$217.09M
TMDXTransMedics Group$441.54M$157.37M
ADMAADMA Biologics$426.45M$121.98M
HNGEHinge Health$390.40M$123.83M
MIRMMirum Pharmaceuticals$336.89M$111.58M
NVSTEnvista-$682.10M
VKTXViking Therapeutics--

TMDX Revenue FAQ

What is TransMedics Group’s yearly revenue?

TransMedics Group's yearly revenue for 2024 was $441.54M, representing an increase of 82.74% compared to 2023. The company's yearly revenue for 2023 was $241.62M, representing an increase of 158.53% compared to 2022. TMDX's yearly revenue for 2022 was $93.46M, representing an increase of 208.83% compared to 2021.

What is TransMedics Group’s quarterly revenue?

TransMedics Group's quarterly revenue for Q2 2025 was $157.37M, a 9.64% increase from the previous quarter (Q1 2025), and a 37.68% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $143.54M, a 18.02% increase from the previous quarter (Q4 2024), and a 48.21% increase year-over-year (Q1 2024). TMDX's quarterly revenue for Q4 2024 was $121.62M, a 11.83% increase from the previous quarter (Q3 2024), and a 49.83% increase year-over-year (Q4 2023).

What is TransMedics Group’s revenue growth rate?

TransMedics Group's revenue growth rate for the last 3 years (2022-2024) was 372.44%, and for the last 5 years (2020-2024) was 1622.14%.

What are TransMedics Group’s revenue streams?

TransMedics Group's revenue streams in c 24 are Product, and Service Revenue. Product generated $273.87M in revenue, accounting 62.03% of the company's total revenue, up 55.56% year-over-year. Service Revenue generated $167.67M in revenue, accounting 37.97% of the company's total revenue, up 155.78% year-over-year.

What is TransMedics Group’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of TransMedics Group was Product. This segment made a revenue of $273.87M, representing 62.03% of the company's total revenue.